Ambria Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
4
- Investments
-
25
- Portfolio
-
13
- Exits
-
11
Ambria Capital General Information
Company Description
Founded in 2019, Ambria Capital is a venture capital investment firm based in San Juan, Puerto Rico. The firm seeks to make investments in the healthcare and technology sectors.
Business Details
Website
www.ambriacap.comYear Founded
Investor Status
Primary Investor Type
Other Investor Types
Corporate Office
- San Juan, PR 00907
- United States
Ambria Capital Investments (25)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Stella (Clinics/Outpatient Services) | 09-May-2023 | Early Stage VC | Clinics/Outpatient Services | Generating Revenue | ||
| HealingMaps | 22-Sep-2022 | Clinics/Outpatient Services | Generating Revenue | |||
| Tyson 2.0 | 21-Sep-2022 | Other Pharmaceuticals and Biotechnology | Generating Revenue | |||
| Clairvoyant (Drug Discovery) | 07-Jul-2022 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Wonder Sciences | 01-Jun-2022 | Clinics/Outpatient Services | Generating Revenue | |||
| Tyson 2.0 | 27-Oct-2021 | Other Pharmaceuticals and Biotechnology | Generating Revenue | |||
| Semasio | 20-Oct-2021 | Media and Information Services (B2B) | Generating Revenue | |||
| Mycrodose | 07-Sep-2021 | Drug Discovery | Startup | |||
| CityRow | 28-Jul-2021 | Later Stage VC | Educational and Training Services (B2C) | Generating Revenue | ||
| NanoPsy | 29-Jun-2021 | Seed Round | Drug Discovery | Generating Revenue |
Ambria Capital Exits (11)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Semasio | 29-Oct-2024 | Merger/Acquisition | |
| CityRow | 24-Jan-2024 | ||
| Cybin (Drug Discovery) | 04-Aug-2023 | ||
| Eleusis | 20-Oct-2022 | ||
| PsyTech (Clinics/Outpatient Services) | 08-Sep-2021 | ||
| Awakn Life Sciences | 23-Jun-2021 | ||
| ATAI Life Sciences | 18-Jun-2021 | ||
| Wesana Health | 06-May-2021 | ||
| Small Pharma | 29-Apr-2021 | Reverse Merger | |
| Reunion Neuroscience | 17-Mar-2021 | Public Investment 2nd Offering |
Ambria Capital Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Ambria Capital Co-Investors (94)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Negev Capital | 7 |
|
|
||
| Phyto Partners |
|
|
|||
| JLS Fund |
|
|
|||
| Sol Global Investments |
|
|
|||
| The Conscious Fund |
|
|
Ambria Capital FAQs
-
What is Ambria Capital?
Founded in 2019, Ambria Capital is a venture capital investment firm based in San Juan, Puerto Rico.
-
When was Ambria Capital founded?
Ambria Capital was founded in 2018.
-
Where is Ambria Capital headquartered?
Ambria Capital is headquartered in San Juan, PR.
-
How many investments has Ambria Capital made?
Ambria Capital has made 25 investments.
-
What has Ambria Capital invested in?
Ambria Capital has made numerous investments in companies like Stella (Clinics/Outpatient Services), HealingMaps, and Tyson 2.0 within the Clinics/Outpatient Services and Pharmaceuticals and Biotechnology industries.
-
What has Ambria Capital invested in recently?
Ambria Capital's latest investment was on 09-May-2023 in Stella (Clinics/Outpatient Services), a company within the Clinics/Outpatient Services industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
